Fastighets AB Trianon (publ) (STO:TRIAN.B)
Sweden · Delayed Price · Currency is SEK 18.70
+0.10 (0.53%)
Jul 29, 2025, 5:29 PM CET
Verve Therapeutics Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Property, Plant & Equipment | 12,485 | 13,377 | 12,474 | 13,048 | 12,836 | 9,658 | Upgrade |
Cash & Equivalents | 142.6 | 124.5 | 109.8 | 90 | 87.4 | 280.1 | Upgrade |
Accounts Receivable | 80 | 27.3 | 23.9 | 20.4 | 16.2 | 23.2 | Upgrade |
Other Receivables | 52.6 | 87.6 | 154 | 40.4 | 142.1 | 28.2 | Upgrade |
Investment In Debt and Equity Securities | 20.6 | 7.3 | 159.6 | - | - | - | Upgrade |
Other Current Assets | - | 12.7 | 11.8 | 19.1 | 20.7 | 24.8 | Upgrade |
Trading Asset Securities | - | - | - | 22.2 | - | - | Upgrade |
Deferred Long-Term Tax Assets | 140.6 | 146.5 | 110.7 | 35.5 | 55.5 | 57.4 | Upgrade |
Other Long-Term Assets | 519.3 | 509.6 | 586 | 522.6 | 422.9 | 231.7 | Upgrade |
Total Assets | 13,441 | 14,292 | 13,630 | 13,798 | 13,581 | 10,303 | Upgrade |
Current Portion of Long-Term Debt | 2,373 | 3,227 | 1,861 | 2,980 | 3,412 | 1,487 | Upgrade |
Long-Term Debt | 4,565 | 4,211 | 5,406 | 4,155 | 3,525 | 4,226 | Upgrade |
Long-Term Leases | 182.4 | 182.4 | 181.6 | 181.4 | 163.6 | 194.2 | Upgrade |
Accounts Payable | - | 50.6 | 64.3 | 89.3 | 74.3 | 43 | Upgrade |
Accrued Expenses | - | 37 | 31.5 | 28.1 | 16.7 | 16.1 | Upgrade |
Current Income Taxes Payable | - | 40.6 | 23.1 | 9.5 | 15.8 | 18 | Upgrade |
Current Unearned Revenue | - | 86.2 | 77.5 | 76 | 64.8 | 67.9 | Upgrade |
Other Current Liabilities | 228.5 | 89 | 97.9 | 45.2 | 159.2 | 28.4 | Upgrade |
Long-Term Deferred Tax Liabilities | 898.8 | 935.7 | 841.4 | 855.2 | 857.3 | 586.8 | Upgrade |
Other Long-Term Liabilities | 17.9 | 18.2 | 2.9 | 4.5 | 48.1 | - | Upgrade |
Total Liabilities | 8,265 | 8,877 | 8,609 | 8,425 | 8,337 | 6,668 | Upgrade |
Common Stock | 125.23 | 125.2 | 115.1 | 98.4 | 98.1 | 93.7 | Upgrade |
Additional Paid-In Capital | - | 1,910 | 1,668 | 1,315 | 1,306 | 863 | Upgrade |
Retained Earnings | - | 3,329 | 3,111 | 3,364 | 3,401 | 2,128 | Upgrade |
Comprehensive Income & Other | 5,051 | 50.6 | 126.6 | 595.1 | 412.5 | 447.8 | Upgrade |
Total Common Equity | 5,176 | 5,415 | 5,020 | 5,373 | 5,217 | 3,532 | Upgrade |
Minority Interest | - | - | - | - | 26.6 | 102.9 | Upgrade |
Shareholders' Equity | 5,176 | 5,415 | 5,020 | 5,373 | 5,244 | 3,635 | Upgrade |
Total Liabilities & Equity | 13,441 | 14,292 | 13,630 | 13,798 | 13,581 | 10,303 | Upgrade |
Total Debt | 7,120 | 7,620 | 7,471 | 7,317 | 7,101 | 5,908 | Upgrade |
Net Cash (Debt) | -6,977 | -7,495 | -7,361 | -7,205 | -7,014 | -5,628 | Upgrade |
Net Cash Per Share | -35.52 | -38.25 | -46.28 | -45.80 | -46.34 | -38.03 | Upgrade |
Filing Date Shares Outstanding | 184.37 | 200.37 | 184.12 | 157.51 | 157.01 | 149.86 | Upgrade |
Total Common Shares Outstanding | 184.37 | 200.37 | 184.12 | 157.51 | 157.01 | 149.86 | Upgrade |
Book Value Per Share | 28.07 | 26.77 | 26.58 | 30.33 | 30.60 | 20.58 | Upgrade |
Tangible Book Value | 5,176 | 5,415 | 5,020 | 5,373 | 5,217 | 3,532 | Upgrade |
Tangible Book Value Per Share | 28.07 | 26.77 | 26.58 | 30.33 | 30.60 | 20.58 | Upgrade |
Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.